CN Patent

CN104056250A — 脂肽组合物和相关方法

Assigned to Hydra Biosciences LLC · Expires 2014-09-24 · 12y expired

What this patent protects

一种脂肽组合物和相关方法。本发明提供新的粉末达托霉素制剂，其在固态时具有改善的化学稳定性和较快的重建时间。该组合物的一些实例包含达托霉素和蔗糖。

USPTO Abstract

一种脂肽组合物和相关方法。本发明提供新的粉末达托霉素制剂，其在固态时具有改善的化学稳定性和较快的重建时间。该组合物的一些实例包含达托霉素和蔗糖。

Drugs covered by this patent

Patent Metadata

Patent number
CN104056250A
Jurisdiction
CN
Classification
—
Expires
2014-09-24
Drug substance claim
No
Drug product claim
No
Assignee
Hydra Biosciences LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.